复发霍奇金淋巴瘤的挽救治疗 - Suppr | 超能文献

Salvage treatment for Hodgkin's disease in relapse.

作者信息

Bergsagel D E

出版信息

J Clin Oncol. 1987 Apr;5(4):525-6. doi: 10.1200/JCO.1987.5.4.525.

DOI:10.1200/JCO.1987.5.4.525

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Salvage treatment for Hodgkin's disease in relapse.复发霍奇金淋巴瘤的挽救治疗

J Clin Oncol. 1987 Apr;5(4):525-6. doi: 10.1200/JCO.1987.5.4.525.

2

Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.近期淋巴瘤和霍奇金病挽救性化疗方案的结果。

Semin Hematol. 1988 Apr;25(2 Suppl 2):47-50.

3

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.米托胍腙、异环磷酰胺、甲氨蝶呤、依托泊苷（MIME）联合化疗及粒细胞集落刺激因子（G-CSF）能够有效动员霍奇金淋巴瘤和非霍奇金淋巴瘤患者的外周血祖细胞。

Bone Marrow Transplant. 1998 May;21(9):873-8. doi: 10.1038/sj.bmt.1701192.

4

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.卡铂、依托泊苷和异环磷酰胺高剂量化疗后自体干细胞救援治疗复发或难治性恶性淋巴瘤患者：一项I/II期研究。

Bone Marrow Transplant. 1997 Dec;20(11):953-9. doi: 10.1038/sj.bmt.1701002.

5

MIME combination chemotherapy in recurrent or refractory lymphoproliferative malignancies. A phase II study.复发性或难治性淋巴增殖性恶性肿瘤的MIME联合化疗：一项II期研究。

Acta Oncol. 1991;30(1):17-21. doi: 10.3109/02841869109091807.

6

High-dose etoposide and melphalan, and autologous bone marrow transplantation for patients with advanced Hodgkin's disease: importance of disease status at transplant.大剂量依托泊苷和美法仑及自体骨髓移植治疗晚期霍奇金病患者：移植时疾病状态的重要性

J Clin Oncol. 1993 Apr;11(4):704-11. doi: 10.1200/JCO.1993.11.4.704.

7

Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.高剂量环磷酰胺、依托泊苷和顺铂序贯自体骨髓或外周血干细胞移植治疗预后不良的霍奇金淋巴瘤或非霍奇金淋巴瘤的I/II期研究

Bone Marrow Transplant. 1993 Oct;12(4):337-45.

8

Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease.大剂量环磷酰胺、卡莫司汀和依托泊苷联合自体骨髓移植治疗复发性霍奇金淋巴瘤后的反应和生存预后因素。

J Clin Oncol. 1989 Feb;7(2):179-85. doi: 10.1200/JCO.1989.7.2.179.

9

Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.异环磷酰胺-卡铂-依托泊苷（ICE）与阿糖胞苷-顺铂-地塞米松（DHAP）作为复发或难治性淋巴瘤患者挽救性化疗的比较

Cancer Invest. 2008 May;26(4):401-6. doi: 10.1080/07357900701788098.

10

[Subcutaneous inflammatory edema induced by MINE chemotherapy].[米氮平诱导的皮下炎性水肿]

Ann Dermatol Venereol. 2001 Apr;128(4):534-7.